Provided by Tiger Trade Technology Pte. Ltd.

Trevi Therapeutics, Inc.

13.91
-0.2700-1.90%
Post-market: 13.910.00000.00%19:30 EDT
Volume:2.08M
Turnover:29.23M
Market Cap:1.98B
PE:-39.54
High:14.55
Open:14.38
Low:13.72
Close:14.18
52wk High:20.22
52wk Low:9.28
Shares:142.00M
Float Shares:118.00M
Volume Ratio:0.95
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3518
EPS(LYR):-0.3173
ROE:-19.66%
ROA:-13.82%
PB:6.14
PE(LYR):-43.83

Loading ...

Stock Track | Trevi Therapeutics Soars 5.27% in Intraday Trading After Stifel Raises Target Price to $30

Stock Track
·
May 08

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Joint (JYNT) and ImmunityBio (IBRX)

TIPRANKS
·
May 08

Stock Track | Trevi Therapeutics Plummets 5.39% Intraday on Q1 Loss Worse Than Expected

Stock Track
·
May 06

Morgan Stanley Remains a Buy on Trevi Therapeutics (TRVI)

TIPRANKS
·
May 06

Trevi Therapeutics Q1 Loss Unchanged

MT Newswires Live
·
May 06

Trevi Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Trevi Therapeutics Q1 net loss widens as R&D costs rise

Reuters
·
May 06

BRIEF-Trevi Therapeutics Q1 Net Income USD -13.192 Million

Reuters
·
May 06

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
May 06

Trevi Therapeutics Q1 EPS USD -0.09

THOMSON REUTERS
·
May 06

Trevi Therapeutics to present Phase 2b CORAL nalbuphine ER data at ATS conference

Reuters
·
May 01

Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

THOMSON REUTERS
·
May 01

Trevi Therapeutics to report Q1 results, host corporate update call May 5

Reuters
·
Apr 29

Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

THOMSON REUTERS
·
Apr 29

Why Trevi Therapeutics (TRVI) Is Down 7.3% After $150.8M Equity Raise And Share Authorization Boost

Simply Wall St.
·
Apr 28

Trevi Therapeutics to host investor and analyst day in May

Reuters
·
Apr 24

Trevi Therapeutics Inc : Leerink Partners Raises Target Price to $25 From $21

THOMSON REUTERS
·
Apr 21

Trevi Therapeutics closes USD 173 million follow-on stock offering at USD 13 per share

Reuters
·
Apr 21

Press Release: Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dow Jones
·
Apr 21

Sector Update: Health Care Stocks Higher Pre-Bell Friday

MT Newswires Live
·
Apr 17